<SEC-DOCUMENT>0001193125-22-221191.txt : 20220815
<SEC-HEADER>0001193125-22-221191.hdr.sgml : 20220815
<ACCEPTANCE-DATETIME>20220815160507
ACCESSION NUMBER:		0001193125-22-221191
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20220815
DATE AS OF CHANGE:		20220815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIONS GATE ENTERTAINMENT CORP /CN/
		CENTRAL INDEX KEY:			0000929351
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MOTION PICTURE & VIDEO TAPE PRODUCTION [7812]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14880
		FILM NUMBER:		221165633

	BUSINESS ADDRESS:	
		STREET 1:		2700 COLORADO AVENUE
		STREET 2:		SUITE 200
		CITY:			SANTA MONICA
		STATE:			CA
		ZIP:			90404
		BUSINESS PHONE:		877-848-3866

	MAIL ADDRESS:	
		STREET 1:		250 HOWE STREET
		STREET 2:		20TH FLOOR
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6C #R8

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BERINGER GOLD CORP
		DATE OF NAME CHANGE:	19970618

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GUYANA GOLD CORP
		DATE OF NAME CHANGE:	19960212
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>d355544ddefa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML><HEAD>
<TITLE>DEFA14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
INFORMATION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(AMENDMENT NO.&nbsp;&nbsp;&nbsp;&nbsp;) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9745; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a Party other than the Registrant&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B></B>&#9744;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only (as permitted by Rule
<FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT> </B></P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9745;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material Pursuant to <FONT STYLE="white-space:nowrap">Rule14a-12</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>LIONS GATE ENTERTAINMENT CORP. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9745;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
<FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SUPPLEMENT TO PROXY STATEMENT </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>FOR THE 2022 ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To Be Held September&nbsp;13, 2022 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On or about July&nbsp;28, 2022, Lions Gate Entertainment Corp. (the &#147;Company&#148;) furnished or otherwise made available to shareholders
its proxy statement (the &#147;Proxy Statement&#148;) describing the matters to be voted upon at the Company&#146;s Annual General and Special Meeting of Shareholders (the &#147;Annual Meeting&#148;) to be held on Tuesday, September&nbsp;13, 2022,
beginning at 1:00 p.m., Pacific Time, at the Company&#146;s head office in Canada at Dentons Canada, 250 Howe Street, 20<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Floor, Vancouver, British Columbia, V6C 3R8. This supplement (this
&#147;Supplement&#148;) provides some additional information for shareholders to consider with respect to <B>Proposal No.</B><B></B><B>&nbsp;3 (Advisory Vote to Approve Executive Compensation) </B>and should be read in conjunction with the Proxy
Statement. This Supplement is first being furnished or otherwise made available to shareholders on or about August&nbsp;15, 2022. All capitalized terms used but not defined in this Supplement have the meanings ascribed to them in the Proxy
Statement. Except as described in this Supplement, the information provided in the Proxy Statement continues to apply and should be considered in voting your shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Amendment to Chief Executive Officer Employment Agreement </U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;12, 2022, the Compensation Committee approved the Company&#146;s exercising its option under its employment agreement with Jon
Feltheimer, the Company&#146;s Chief Executive Officer (the &#147;Agreement&#146;), to extend the term of the Agreement through August&nbsp;21, 2025. The Committee also approved certain amendments to the Agreement. Below is a summary of the terms of
the Agreement, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Agreement, Mr.&nbsp;Feltheimer receives an annual base salary of $1,500,000 and is eligible to
receive an annual performance bonus based on such performance criteria as established by the Committee, with the target bonus commencing with the Company&#146;s 2023 fiscal year being $7,000,000. Any portion of Mr.&nbsp;Feltheimer&#146; s annual
bonus that exceeds $1,500,000 for a particular year may be paid to him in the form of fully vested Company common shares. The Agreement also provides for Mr.&nbsp;Feltheimer to participate in the Company&#146;s usual benefit programs for executives
at his level, as well as Company-provided life and disability insurance coverage, reasonable club membership dues and limited use of the Company&#146;s private aircraft. The Agreement also provides for Mr.&nbsp;Feltheimer to receive, subject in each
case to approval by the Committee and Mr.&nbsp;Feltheimer&#146;s continued employment through the applicable date of grant, the following equity-based awards for each of the Company&#146;s 2024, 2025 and 2026 fiscal years (the &#147;Annual
Grants&#148;): (i) a time-vesting award of restricted share units (&#147;RSUs&#148;) with respect to the Company&#146;s Class&nbsp;B <FONT STYLE="white-space:nowrap">non-voting</FONT> shares (&#147;Class&nbsp;B Shares&#148;); (ii) a time-vesting
award of stock options or share appreciation rights (&#147;SARs&#148;) with respect to the Class&nbsp;B Shares; and (iii)&nbsp;a performance-vesting award of RSUs with respect to the Class&nbsp;B Shares. The aggregate grant date value of each Annual
Grant will be $6,000,000 (the &#147;Annual Grant Value&#148;). The number of shares subject to the three awards comprising each Annual Grant will be determined, in the case of each of the two RSU awards, by dividing
<FONT STYLE="white-space:nowrap">one-third</FONT> of the Annual Grant Value by the closing price of a Class&nbsp;B Share on the date of that Annual Grant and, in the case of the award of options or SARs, by dividing
<FONT STYLE="white-space:nowrap">one-third</FONT> of the Annual Grant Value by the <FONT STYLE="white-space:nowrap">per-share</FONT> value of the award as of the grant date based on the methodology then used by the Company to value options and
similar awards for financial statement purposes. Each Annual Grant will be scheduled to vest in equal installments on the first three anniversaries of the applicable grant date. Each of the Annual Grants will be granted under the Company&#146;s 2019
Performance Incentive Plan or a successor equity compensation plan of the Company. Except as noted below, the vesting of each installment of the Annual Grants is subject to Mr.&nbsp;Feltheimer&#146;s continued employment through the applicable
vesting date. In addition, the vesting of the performance-based RSU Annual Grants is contingent on achievement of performance metrics to be determined by the Committee for the <FONT STYLE="white-space:nowrap">12-month</FONT> period ending on the
applicable vesting date. The Agreement provides that each of the Annual Grants described above may be settled in cash, the Class&nbsp;B Shares, the Company&#146;s Class&nbsp;A voting shares, or a combination thereof, as determined by the Committee,
with the amount of the payment in each case determined based on the value of the Class&nbsp;B Shares at the time of payment (less the applicable exercise price in the case of options and SARs). The Committee also approved the grant of
Mr.&nbsp;Feltheimer on July&nbsp;27, 2022 of 290,433 time-vesting RSUs and 290,433 performance-vesting RSUs that are generally subject to the same vesting conditions described above. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event Mr.&nbsp;Feltheimer&#146;s employment is terminated by the Company without
cause or by him for good reason (as such terms are defined in the Agreement), he would be entitled to a cash severance payment equal to the present value of his base salary through August&nbsp;21, 2025, as well as Company payment of his premiums for
continued health coverage for up to six months following his termination and his premiums for continued life and disability insurance through August&nbsp;21, 2025. In addition, Mr.&nbsp;Feltheimer would be entitled to payment of the target amount of
his annual bonus for the fiscal year in which his termination occurs. Mr.&nbsp;Feltheimer&#146;s equity awards granted by the Company pursuant to the Agreement prior to his termination (including the July 2022 grants noted above), to the extent then
outstanding and unvested, would become fully vested upon his termination (and if the Annual Grant for the fiscal year in which his termination occurs has not previously been granted, that Annual Grant would be made and would fully vest upon his
termination). If Mr.&nbsp;Feltheimer&#146;s employment is terminated by the Company without cause or by him for good reason and such termination occurs on or within 12 months following a change in control of the Company (as defined in the
Agreement), he would be entitled to the severance benefits described above, except that his cash severance would be the greater of the present value of his base salary through August&nbsp;21, 2025 and $6,000,000. In each case,
Mr.&nbsp;Feltheimer&#146;s right to receive the severance payments described above would be subject to his execution of a release of claims in favor of the Company. In the event Mr.&nbsp;Feltheimer&#146;s employment with the Company terminates due
to his death or disability, his equity awards granted by the Company pursuant to the Agreement (and the July 2022 grants), to the extent then outstanding and unvested, would become fully vested as of the date of such termination. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>VOTING MATTERS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>This Supplement does
not change the proposals to be acted upon at the Annual Meeting, which are described in the Proxy Statement</B>. As a shareholder, your vote is very important and the Board of Directors of the Company encourages you to exercise your right to vote
whether or not you plan to attend the Annual Meeting. If you have already voted by Internet, telephone or by mail, you do not need to take any action unless you wish to change your vote. Proxy voting instructions already returned by shareholders
(via Internet, telephone or mail) will remain valid and will be voted at the Annual Meeting unless revoked. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By Order of The Board of Directors,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g355544g0812220904745.jpg" ALT="LOGO">
</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Jon Feltheimer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><I>Chief Executive Officer</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Santa Monica, California</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Vancouver, British Columbia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">August&nbsp;15, 2022</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g355544g0812220904745.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g355544g0812220904745.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  G '@# 2(  A$! Q$!_\0
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MG0;O]XK*<GJ=HS5O7?EUGPT[?=&H."?0FVG _P /QI;_ )\:Z*HZBTNV_#=
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M%I;R3Y_[X4T5NT4 <%IFMS6%A!X,LX_^*ALX5MQOQY:1J-JSD]QMPVT?-GC
MZUV&F:?%I6FV]C;EC'"@0%CDL>['W)R3]:** +M%%% !1110 4444 %%%% !
..1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
